These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10799431)

  • 1. Angiotensin for septic shock unresponsive to noradrenaline.
    Yunge M; Petros A
    Arch Dis Child; 2000 May; 82(5):388-9. PubMed ID: 10799431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe septic shock unresponsive to noradrenaline.
    Wray GM; Coakley JH
    Lancet; 1995 Dec; 346(8990):1604. PubMed ID: 7500755
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of hypotension in septic shock.
    Pastor CM; Morel DR
    Lancet; 1996 Mar; 347(9001):622; author reply 622-3. PubMed ID: 8596355
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of hypotension in septic shock.
    Whiteley SM; Dade JP
    Lancet; 1996 Mar; 347(9001):622. PubMed ID: 8596354
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiotensin II: a new approach for refractory shock management?
    Kimmoun A; Levy B
    Crit Care; 2014 Dec; 18(6):694. PubMed ID: 25645552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II in septic shock.
    Jadhav AP; Sadaka FG
    Am J Emerg Med; 2019 Jun; 37(6):1169-1174. PubMed ID: 30935784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noradrenaline as a vasoactive agent in septic shock.
    Tordoff SG; Thompson JL; Williams AW
    Intensive Care Med; 2000 May; 26(5):648. PubMed ID: 10923747
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversal of 'refractory septic shock' by infusion of amrinone and angiotensin II in an anthracycline-treated patient.
    Ryding J; Heslet L; Hartvig T; Jønsson V
    Chest; 1995 Jan; 107(1):201-3. PubMed ID: 7813278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study.
    Chawla LS; Busse L; Brasha-Mitchell E; Davison D; Honiq J; Alotaibi Z; Seneff MG
    Crit Care; 2014 Oct; 18(5):534. PubMed ID: 25286986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II for the treatment of septic shock in a neutropenic patient with T-cell acute lymphoblastic leukaemia.
    Bui AD; Helgeson SA; Guru PK; Sanghavi DK
    BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32595128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II in Refractory Septic Shock.
    Antonucci E; Gleeson PJ; Annoni F; Agosta S; Orlando S; Taccone FS; Velissaris D; Scolletta S
    Shock; 2017 May; 47(5):560-566. PubMed ID: 27879559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose vasopressin in the treatment of vasodilatory septic shock.
    Malay MB; Ashton RC; Landry DW; Townsend RN
    J Trauma; 1999 Oct; 47(4):699-703; discussion 703-5. PubMed ID: 10528604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II in Decompensated Cirrhosis Complicated by Septic Shock.
    Coleman PJ; Nissen AP; Kim DE; Ainsworth CR; McCurdy MT; Mazzeffi MA; Chow JH
    Semin Cardiothorac Vasc Anesth; 2020 Sep; 24(3):266-272. PubMed ID: 31540560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terlipressin bolus induces systemic vasoconstriction in septic shock.
    Peters MJ; Booth RA; Petros AJ
    Pediatr Crit Care Med; 2004 Mar; 5(2):112-5. PubMed ID: 14987338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressin infusion in children with catecholamine-resistant septic shock.
    Vasudevan A; Lodha R; Kabra SK
    Acta Paediatr; 2005 Mar; 94(3):380-3. PubMed ID: 16028663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. THE ROLE OF ANGIOTENSIN -2 IN THE PATHOGENESIS OF SEPTIC SHOCK DURING MULTIORGAN DYSFUNCTION SYNDROME (REVIEW).
    Rurua M; Machavariani K; Sanikidze T; Shoshiashvili V; Pachkoria E; Ratiani L
    Georgian Med News; 2022 Feb; (323):157-161. PubMed ID: 35271489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-II: more than just another vasoconstrictor to treat septic shock-induced hypotension?*.
    Asfar P; Chawla L; Lerolle N; Radermacher P
    Crit Care Med; 2014 Aug; 42(8):1961-3. PubMed ID: 25029144
    [No Abstract]   [Full Text] [Related]  

  • 18. Vasodilatory shock in the ICU and the role of angiotensin II.
    Wakefield BJ; Sacha GL; Khanna AK
    Curr Opin Crit Care; 2018 Aug; 24(4):277-285. PubMed ID: 29877879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressor therapy in critically ill patients with shock.
    Russell JA
    Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II and Vasopressin for Vasodilatory Shock: A Critical Appraisal of Catecholamine-Sparing Strategies.
    Heavner MS; McCurdy MT; Mazzeffi MA; Galvagno SM; Tanaka KA; Chow JH
    J Intensive Care Med; 2021 Jun; 36(6):635-645. PubMed ID: 32223515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.